| Entries |
| Document | Title | Date |
|---|
| 20080234341 | Carisoprodol and Phenytoin Methods - A method of using carisoprodol comprises informing a user that co-administration of carisoprodol with steady-state phenyloin results in an increase in free phenyloin blood levels, a decrease in total phenyloin blood levels, or both. In another embodiment, a method of using carisoprodol comprises informing a user that when co-administering carisoprodol with steady-state phenyloin, the level of free phenyloin in a patient serum should be monitored, the level of total phenyloin should be monitored, or both. Also included are methods and articles of manufacture. | 09-25-2008 |
| 20080255217 | PREVENTIVE OR THERAPEUTIC AGENT FOR CARDIAC DYSFUNCTION OR MYOCARDIAL INJURY CAUSED BY ISCHEMIA OR ISCHEMIA REPERFUSION - Disclosed herein is at least a method of preventing or treating cardiac dysfunction or myocardial injury caused by ischemia or ischemia reperfusion | 10-16-2008 |
| 20080269306 | Antidepressant Medicament Comprising Idazoxan and a Selective Serotonin Reuptake Inhibitor - Use of Idazoxan or an active enantiomer thereof, and treatment of patients receiving therapy with selective serotonin uptake inhibitor(s), such as Fluoxetine, Citalopram, Paroxetine, Sertraline and Fluvoxamine, are described. The patients being treated are in particular those who are suffering from severe depression, anxiety-depression, PTSD (Post Traumatic Stress Disorder), or ADHD (Attention Deficit Hyperactive Disorder). | 10-30-2008 |
| 20090012138 | 4-IMIDAZOLINES - The present invention relates to compounds of formula | 01-08-2009 |
| 20090062359 | Injectable capsaicin with non-local anesthetic sodium channel-blocker adjunctive agent - Disclosed in certain embodiments is a method for relieving pain at a site in a human or animal in need thereof, comprising administering by injection or infiltration, a dose of a capsaicinoid and coadministering a non-anesthetic sodium channel blocker. | 03-05-2009 |
| 20090270472 | METHOD TO USE OXYMETAZOLINE TO INTERRUPT THE DEVELOPMENT OF THE COMMON COLD SYNDROME - This invention describes a new manner of treating the common cold. It claims that treatment with Oxymetazoline nasal spray at the time of onset of first cold symptom(s) can interrupt the development of the common cold syndrome and result in cure of the cold. | 10-29-2009 |
| 20090286839 | PHYTONUTRIENT COMPOSITIONS FROM MUSHROOMS OR FILAMENTOUS FUNGI AND METHODS OF USE - This invention is directed to treating disease states or conditions associated with the treatment and prevention of neurodegeneration and neurodegenerative disease states, and treatment of radiation damage. The invention relates to novel phytonutrient compositions and compounds comprising L-ergothioneine and/or selenium. The invention also provides a method of administering these compositions and combinations to humans or animals in need thereof. | 11-19-2009 |
| 20090306161 | METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS - Described herein are compounds for and methods of treating conditions or diseases in a subject by administering to the subject a pharmaceutical composition containing an effective amount of an α-adrenergic modulator. The compounds and methods are also useful for alleviating types of pain, both acute and chronic. | 12-10-2009 |
| 20100113544 | Suppressant for cerebral infarction attributed to long-time ischemia - An object of the present invention is to provide a cerebral infarction suppressant which is effective for brain tissue necrosis after long-time ischemia as in actual cerebral infarction and has fewer side effects. The cerebral infarction suppressant of the present invention is characterized in that histidine is contained and the cerebral infarction is attributed to long-time ischemia. | 05-06-2010 |
| 20130072531 | SOLID DISPERSION COMPRISING AN ANTI-HIV AGENT - The present invention relates to solid dispersions comprising a compound of formula | 03-21-2013 |
| 20140249195 | 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF - Muscarinic acetylcholine receptor antagonists and methods of using them for the treatment of muscarinic acetylcholine receptor-mediated diseases, such as pulmonary diseases, are provided | 09-04-2014 |
| 20160250188 | METHODS FOR TREATMENT OF MUSCULAR DYSTROPHIES | 09-01-2016 |
